Purapharm Corp Ltd
About
PuraPharm Corp. Ltd. is an investment holding company, which engages in the research and development, production and sale of concentrated Chinese medicine granule (CCMG) products and Chinese healthcare products, as well as rendering of Chinese medical diagnostic services. It operates through the following segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics and Plantation.
The China CCMG segment manufactures, sells, and researches modernized Chinese medicines in Mainland China. The Hong Kong CCMG segment handles sale of CCMG products excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment consists of operations in Hong Kong, the USA and Japan. The Clinics segment provides Chinese medical diagnostic services.
The Plantation segment focuses on the plantation and trading of raw Chinese herbs, and manufacture and sale of TCM decoction pieces. The company was founded by Yu Ling Chan on May 5, 1998 and is headquartered in Hong Kong.
Growth
PuraPharm International (H.K.) Ltd. is an established company in the Chinese medicine industry, positioned as a market leader in Concentrated Chinese Medicine Granules (CCMG) with a 70% market share in Hong Kong. The company has experienced rapid growth and expansion, becoming one of the fastest-growing Chinese medicine companies in the region. PuraPharm has also successfully expanded its presence beyond Hong Kong, obtaining licenses to manufacture and sell CCMG products in China and receiving recognition from the United States Pharmacopeia for its CCMG products.
Achievements
PuraPharm International (H.K.) Ltd. has achieved several significant milestones in its history, including becoming the leading provider of CCMG products in Hong Kong with a 70% market share. The company has also received licensing from the China NMPA to sell CCMG products in China, making it the only non-PRC company with this authorization. Furthermore, PuraPharm is the first Chinese medicine manufacturer to have its CCMG products verified and recognized by the United States Pharmacopeia, highlighting its commitment to quality and innovation in the industry.
Case Studies
PuraPharm International (H.K.) Ltd. has been involved in numerous notable projects and initiatives that have showcased the company's expertise in Chinese medicine modernization. One such project is the development and commercialization of Concentrated Chinese Medicine Granules (CCMG) products, which have become popular among retail customers and Chinese Medical Practitioners. PuraPharm's dedication to research, development, and manufacturing of high-quality Chinese healthcare products has positioned it as a leading provider of modernized Chinese medicine solutions.
Key Events
PuraPharm International (H.K.) Ltd. has celebrated several key events in its history, including obtaining licenses to manufacture and sell CCMG products in China, expanding its reach beyond Hong Kong. The company's recognition by the United States Pharmacopeia for its CCMG products marks a significant milestone in validating the quality and efficacy of its offerings. Furthermore, PuraPharm's cutting-edge R&D and modernized manufacturing facilities have enabled it to provide safe, reliable, and effective Chinese medicine products to a global audience.
Socials
Website
Founded
-
Operating Status
Active
Industry
Health Care
Life Sciences
headquarters
Address
Unit 201–207, 2/F Wireless Centre, Phase One Hong Kong Science Park, Tai Po Hong Kong Hong Kong...
Country
Hong Kong
Employees
662
Key People
Yee Wai Man (Executive Director)
Kwok Keung Leung (Non-Executive Director)
Wing Hung Lam (Chief Financial Officer)
Qiong Ruan (GM-China Sales & Marketing)
Products
NONG’S Concentrated Chinese Medicine Granules
Nong’s® Concentrated Chinese Medicine Granules
CardioClear® 72's
Revenue
406.86 M
Operating Income
Stock Price
$0.66
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
Similar Companies
Welcome to AiDOOS Wiki
AiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
Purapharm Corp Ltd
-
Website
-
Founded
-
-
Industry
Health Care
Life Sciences
-
Address
Unit 201–207, 2/F Wireless Centre, Phase One Hong Kong Science Park, Tai Po Hong Kong Hong Kong...
-
Country
Hong Kong
-
Number of employees
662+
-
Revenue
406.86 M
About Purapharm Corp Ltd
PuraPharm Corp. Ltd. is an investment holding company, which engages in the research and development, production and sale of concentrated Chinese medicine granule (CCMG) products and Chinese healthcare products, as well as rendering of Chinese medical diagnostic services. It operates through the following segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics and Plantation.
The China CCMG segment manufactures, sells, and researches modernized Chinese medicines in Mainland China. The Hong Kong CCMG segment handles sale of CCMG products excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment consists of operations in Hong Kong, the USA and Japan. The Clinics segment provides Chinese medical diagnostic services.
The Plantation segment focuses on the plantation and trading of raw Chinese herbs, and manufacture and sale of TCM decoction pieces. The company was founded by Yu Ling Chan on May 5, 1998 and is headquartered in Hong Kong.
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
